BrightGene Bio-Medical Technology Co

BrightGene Bio-Medical Technology Co Inventory Turnover

The Inventory Turnover Ratio of BrightGene Bio-Medical Technology Co (688166.SS) as of Nov 22, 2026 is 1.65. In the previous year, Inventory Turnover Ratio was 1.49 — a change of 10.51% (higher).

Inventory Turnover

1.65

YoY

10.51%

Last updated:

Inventory Turnover Ratio of BrightGene Bio-Medical Technology Co is 2025 1.65 . Inventory Turnover Ratio of BrightGene Bio-Medical Technology Co was 2024 1.49 . It decreases by 10.51% higher compared to the previous year.

The BrightGene Bio-Medical Technology Co Inventory Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory Turnover
Date
Inventory Turnover
Jan 1, 2018
1.64 CNY
Jan 1, 2019
1.32 CNY
Jan 1, 2020
1.74 CNY
Jan 1, 2021
2.30 CNY
Jan 1, 2022
1.34 CNY
Jan 1, 2023
1.51 CNY
Jan 1, 2024
1.49 CNY
Jan 1, 2025
1.65 CNY
The BrightGene Bio-Medical Technology Co Inventory Turnover history
YEARInventory TurnoverYoY
1.65+10.51%
1.49-1.22%
1.51+12.72%
1.34-41.71%
2.30+32.18%
1.74+31.81%
1.32-19.34%
1.64+8.56%
1.51+12.56%
1.34—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BrightGene Bio-Medical Technology Co Stock analysis

What does BrightGene Bio-Medical Technology Co do? BrightGene Bio-Medical Technology Co., Ltd. generates revenue by researching, developing, and manufacturing biopharmaceuticals, medicines, and special generic active pharmaceutical ingredients and finished dosage forms. The company's product portfolio centers on antifungal, antiviral, and immunosuppressive APIs, alongside other APIs and preparations. Its generic drug offerings specifically include entecavir, caspofungin, micafungin, posaconazole, everolimus, and fondaparinux sodium. The firm sells these products to customers in both domestic and overseas markets. By leveraging its capabilities in producing essential active pharmaceutical ingredients and finished dosage forms, the company serves the broader pharmaceutical sector through its established manufacturing and research operations. BrightGene Bio-Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BrightGene Bio-Medical Technology Co stock

Inventory Turnover Ratio of BrightGene Bio-Medical Technology Co is 1.65 in 2025.

Inventory Turnover Ratio of BrightGene Bio-Medical Technology Co changed from 1.49 to 1.65, representing a 10.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Turnover Ratio BrightGene Bio-Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

Inventory turnover measures how many times inventory is sold and replaced during a period. Higher turnover indicates efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Inventory Turnover Ratio's BrightGene Bio-Medical Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Inventory Turnover Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Inventory Turnover Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — BrightGene Bio-Medical Technology Co

All Key Metrics — BrightGene Bio-Medical Technology Co